IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases

British Journal of Haematology

Volumn 103, Issue 1, 1998, Pages 163-167

  Hernandez J M ^a   Gutierrez N C ^a   Almeida, J ^a   Garcia J L ^a   Sanchez M A ^a   Mateo, G ^a   Rios A ^a   San Miguel, J F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Cytogenetics; GM CSF; IL 4; IL 6; Multiple myeloma

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BONE MARROW CULTURE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA CONTENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; KARYOTYPING; METAPHASE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BONE MARROW CELLS; DNA, NEOPLASM; DRUG COMBINATIONS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; INTERLEUKIN-6; KARYOTYPING; METAPHASE; MIDDLE AGED; MITOSIS; MULTIPLE MYELOMA; PLOIDIES; TUMOR CELLS, CULTURED;

EID: 7844250140     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00951.x     Document Type: Article

References (26)

1. Brigaudeau, C., Trimoreau, F., Gachard, N., Rouzier, E., Jaccard, A., Borderssoule, D. & Praloran, V. (1997) Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 days bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method. British Journal of Haematology, 96, 594-600.
2. Dewald, G.W., Kyle, R.A., Hicks, G.A. & Greipp, P.R. (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cells leukemia, or amyloidosis. Blood, 66, 380-390.
3. Drach, J., Schuster, J., Nowotny, H., Angerler, J., Rosenthal, F., Fiegl, M., Rothermundt, C., Gsur, A., Jäger, U., Heinz, R., Lechner, K., Ludwig, H. & Huber, H. (1995) Multiple myeloma: high incidence chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Research, 55, 3854-3859.
4. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-854.
5. Dutcher, J.P., Venkatraj, U., Makower, D. & Wiernik, P.H. (1997) Interleukin-4 is a pleiotropic cytokine with effects on B-cell malignancies. Leukemia Research, 21, 17-19.
6. Facon, T., Laï, J.L., Nataf, E., Preudhomme, C., Zandecki, M., Hammad, M., Wattel, E., Jouet, J.P. & Bauters, F. (1993) Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. British Journal of Haematology, 84, 743-745.
7. García Sanz, R., Orfao, A., González, M., Moro, M.J., Hernández, J.M., Ortega, F., Borrego, D., Carnero, M., Casanova, F., Jiménez, R., Portero, J.A. & San Miguel, J.F. (1995) Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. British Journal of Haematology, 90, 106-112.
8. Gould, J., Alexanian, R., Goodacre, A., Pathak, S., Hecht, B. & Barlogie, B. (1988) Plasma cell karyotype in multiple myeloma. Blood, 71, 453-456.
9. Herrmann, F., Andreeff, M., Gruss, H.J., Brach, M.A., Lübbert, M. & Mertelsmann, R. (1991) Interleukin-4 inhibits growth of multiple myeloma by suppressing interleukin-6 expression. Blood, 78, 2070-2074.
10. ISCN (1995) Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). Karger, Basel.
11. Klein, B., Zhang, X.G., Lu, Z.Y. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
12. Kyrstsonis, M.C., Dedoussis, G., Baxevanis, C., Stamatelou, M. & Maniatis, A. (1996) Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM). British Journal of Haematology, 92, 420-422.
13. Laï, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J.P., Bauters, A. & Facon, T. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85, 2490-2497.
14. Mainou-Fowler, T., Craig, V.A., Copplestone, J.A., Hamon, M.D. & Prentice, A.G. (1994) Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression, and is inhibited by IL-4. Blood, 84, 2297-2304.
15. Orfao, A., García-Sanz, R., López-Berges, M.C., Vidriales, M.B., González, M., Caballero, M.D. & San Miguel, J.F. (1994) A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique. Cytometry, 17, 332-339.
16. San Miguel, J.F., García-Sanz, R., González, M. & Orfao, A. (1995) Immunophenotype and DNA cell content in multiple myeloma. Baillière's Clinical Haematology, 8, 735-759.
17. Sawamura, M., Murakami, H., Tamura, J., Matsuhima, T., Sato, S., Naruse, T. & Tsuchiya, J. (1994) Tumour necrosis factor-α and interleukin 4 promote the differentiation of myeloma cell precursors in multiple myeloma. British Journal of Haematology, 88, 17-23.
18. Sawyer, J.R., Waldron, J.A., Jagannath, S. & Bartlogie, B. (1995) Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genetics and Cytogenetics, 82, 41-49.
19. Smadja, N.V., Louvet, C., Isnard, F., Dutel, J.L., Grange, M.J., Varette, C. & Krulik, M. (1995) Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques. British Journal of Haematology, 90, 619-624.
20. Tabernero, D., San Miguel, J.F., García-Sanz, R., Nájera, M., García-Isidoro, M., Pérez-Simón, J.A., González, M., Wiegant, J., Raap, A.K. & Orfao, A. (1996) Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes. American Journal of Pathology, 149, 153-161.
21. Tricot, G., Sawyer, J.R., Jagannath, S., Desikan, K.R., Siegel, D., Naucke, S., Mattox, S., Bracy, D., Munshi, N. & Barlogie, B. (1997) Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants. Journal of Clinical Oncology, 15, 2659-2666.
22. Van den Berghe, H. (1989) Chromosomes in plasma-cell malignancies. European Journal of Haematology, 43, (Suppl. 51), 47-51.
23. Weh, H.J., Bartl, R., Seeger, D., Selbach, J., Kuse, R. & Hossfeld, D.K. (1995) Correlations between karyotype and cytologic findings in multiple myeloma. Leukemia, 9, 2119-2122.
24. Weh, H.J., Gutensohn, K., Selbach, J., Kruse, R., Wacker-Backhaus, G., Seeger, D., Fiedler, W., Fett, W. & Hossfeld, D.K. (1993) Karyotype in multiple myeloma and plasma cell leukaemia. European Journal of Cancer, 29A, 1269-1273.
25. Zandecki, M., Laï, J.L. & Facon, T. (1996) Multiple myeloma: almost all patients are cytogenetically abnormal. British Journal of Haematology 94, 217-227.
26. Zhang, X., Bataille, R., Jourdan, M., Saeland, S., Banchereau, J., Mannoni, P. & Klein, B. (1990) Granulocyte-macrophage colony stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood, 76, 2599-2605.